Video Intervention for Prostate Cancer Trial Representation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a video intervention to increase diversity in prostate cancer clinical trials by encouraging participation from racial and ethnic minority groups. The study explores various methods to overcome barriers, such as providing information through videos to patients and training doctors to improve communication. It takes place at a hospital primarily serving Latino and Black communities. Patients with prostate cancer receiving treatment at LBJ Hospital may be eligible if they can join an open prostate cancer trial and provide informed consent. As an unphased trial, this study offers a unique opportunity to contribute to research that seeks to make clinical trials more inclusive and accessible.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this video intervention is safe?
Research has shown that video programs in prostate cancer care are generally safe. A review of digital interactive programs found positive results for prostate cancer survivors, demonstrating safety and effectiveness without major side effects. Additionally, tests of video programs like the W.O.R.D. program for Black men with prostate cancer reported no negative effects. These findings suggest that such video programs are well-received and do not pose significant safety risks for participants.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to enhance prostate cancer care through education and communication. Unlike traditional treatments that focus solely on medical intervention, this trial uses video interventions to better connect with patients, particularly those from Latino and Black communities at LBJ Hospital. Additionally, by conducting educational sessions for oncology providers, the trial aims to improve cultural competency and patient-centered communication, potentially improving overall patient outcomes and satisfaction. This approach is unique because it targets the healthcare experience itself, aiming to bridge communication gaps and make care more effective and inclusive.
What evidence suggests that these interventions could be effective for increasing minority representation in prostate cancer trials?
Research has shown that videos can effectively teach patients about prostate cancer. One study found that videos improved understanding and decision-making regarding prostate cancer screening. Another study, featuring the W.O.R.D. on prostate cancer video designed for Black men, demonstrated increased viewer engagement and awareness. These video tools simplify complex health topics and may encourage patients to take a more active role in their care. In this trial, participants will receive a video intervention to enhance their understanding of prostate cancer and treatment options. This evidence suggests that videos could aid patients in learning about prostate cancer and considering treatment options.678910
Who Is on the Research Team?
Debanjan Pain, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This study is for men with prostate cancer who are eligible to join clinical trials, especially those from racial and ethnic minority groups. There are no specific inclusion or exclusion criteria listed.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive culturally tailored video interventions and educational sessions are conducted with oncology providers
Follow-up
Participants are monitored for safety and effectiveness after intervention
What Are the Treatments Tested in This Trial?
Interventions
- Video Intervention
Trial Overview
The trial is testing whether showing a video can help increase the number of minority participants enrolling in prostate cancer clinical trials at Lyndon B. Johnson Hospital.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
The interventions will be conducted at Lyndon B. Johnson (LBJ) Hospital, a safety net facility that cares for a majority Latino and/or Black patient population.
The investigator will conduct multiple one-hour educational sessions focused on participant-centered communication and cultural competency with the 42 oncology fellows during their academic half-days. Fellows attending the educational sessions will be invited to complete a Likert-style course evaluation form and provide open-ended feedback."
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Citations
Informing Men about Prostate Cancer Screening - PMC
To explore the effectiveness of presenting health information on prostate cancer screening using video, internet, and written interventions on patient decision ...
ProtecT Trial 15-Year Data Shows Low Prostate Cancer ...
We wanted to establish the effectiveness of treating PSA-detected prostate cancer at an early stage, using one of the three options that have ...
Exercise Interventions for Patients with Prostate Cancer
So, our hypothesis was that if done together, exercising as a team could result in better outcomes for the patient, for the partner, and for the health of their ...
Fifteen-Year Outcomes after Monitoring, Surgery, or ...
After 15 years of follow-up, prostate cancer–specific mortality was low regardless of the treatment assigned.
Impact of Multimodal Telerehabilitation in Rural Patients ...
Prostate cancer patients receiving androgen deprivation therapy frequently experience debilitating side effects significantly affecting their quality of life.
The impact of digital interactive interventions on survivorship ...
The impact of digital interactive interventions on survivorship outcomes in prostate cancer: a systematic narrative review ... prostate cancer at high risk ...
ProtecT Trial 15-Year Data Shows Low Prostate Cancer ...
ProtecT Trial 15-Year Data Shows Low Prostate Cancer Mortality Across Therapies for Localized Disease, A Journal Club for Patients with Prostate ...
8.
onclive.com
onclive.com/view/dr-mckay-on-real-world-qol-and-safety-outcomes-with-relugolix-in-advanced-prostate-cancerDr McKay on Real-World QOL and Safety Outcomes With ...
Rana R. McKay, MD, discusses findings from the phase 4 OPTYX trial of real-world relugolix in advanced prostate cancer.
the W.O.R.D. on prostate cancer video
Development and assessment of an evidence-based prostate cancer intervention programme for black men: the W.O.R.D. on prostate cancer video Folakem.
Active Surveillance for Prostate Cancer
Active surveillance seeks to avoid or delay the costs of treatment without compromising the ability for cure.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.